A detailed history of Two Sigma Investments, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 227,473 shares of MIRM stock, worth $9.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
227,473
Previous 163,540 39.09%
Holding current value
$9.64 Million
Previous $5.59 Million 58.67%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $2.15 Million - $2.86 Million
63,933 Added 39.09%
227,473 $8.87 Million
Q2 2024

Aug 14, 2024

BUY
$23.57 - $34.85 $192,967 - $285,316
8,187 Added 5.27%
163,540 $5.59 Million
Q1 2024

May 15, 2024

SELL
$24.92 - $30.02 $1.02 Million - $1.22 Million
-40,775 Reduced 20.79%
155,353 $3.9 Million
Q4 2023

Feb 14, 2024

SELL
$27.14 - $34.93 $3.6 Million - $4.63 Million
-132,656 Reduced 40.35%
196,128 $5.79 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $5.56 Million - $7.41 Million
225,674 Added 218.87%
328,784 $10.4 Million
Q2 2023

Aug 14, 2023

BUY
$23.51 - $30.09 $2.42 Million - $3.1 Million
103,110 New
103,110 $2.67 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $1.47 Million - $2.17 Million
-73,544 Reduced 60.63%
47,748 $1 Million
Q2 2022

Aug 15, 2022

SELL
$18.42 - $27.5 $1.37 Million - $2.05 Million
-74,587 Reduced 38.08%
121,292 $2.36 Million
Q1 2022

May 16, 2022

BUY
$15.5 - $23.93 $401,481 - $619,834
25,902 Added 15.24%
195,879 $4.31 Million
Q4 2021

Feb 14, 2022

BUY
$13.05 - $19.35 $191,861 - $284,483
14,702 Added 9.47%
169,977 $2.71 Million
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $855,972 - $1.24 Million
61,360 Added 65.34%
155,275 $3.09 Million
Q2 2021

Aug 16, 2021

SELL
$15.84 - $20.6 $33,343 - $43,363
-2,105 Reduced 2.19%
93,915 $1.62 Million
Q1 2021

May 17, 2021

BUY
$16.29 - $21.92 $1.32 Million - $1.78 Million
81,020 Added 540.13%
96,020 $1.9 Million
Q4 2020

Feb 16, 2021

SELL
$15.75 - $25.45 $595,082 - $961,577
-37,783 Reduced 71.58%
15,000 $262,000
Q3 2020

Nov 16, 2020

BUY
$18.4 - $26.59 $147,016 - $212,454
7,990 Added 17.84%
52,783 $1.02 Million
Q2 2020

Aug 14, 2020

BUY
$11.51 - $20.97 $515,567 - $939,309
44,793 New
44,793 $872,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.56B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.